Search Results 1061-1070 of 18984 for Neutrophil

1. A Study of Nivolumab and Multi-fraction Stereotactic Radiosurgery with or without Ipilimumab in Treating Participants with Recurrent Grade II-III Meningioma - Mayo Clinic

   Absolute neutrophil count >= 1,500/mcL. Platelets >= 100,000/mcL. Total bilirubin =< 1.5 x institutional upper limit of normal (ULN). Aspartate ...

2. Cabozantinib-S-Malate in Treating Patients With Refractory Thyroid Cancer - Mayo Clinic

   Absolute neutrophil count >= 1,500/mcL; Platelet count >= 100,000/mcL; Hemoglobin >= 9 g/dL; Thyroid stimulating hormone (TSH) < lower limit of normal (LLN) ...

3. A Study to Evaluate Lenalidomide and Dexamethasone, with or without Daratumumab, in Treating High-Risk Smoldering Myeloma Patients - Mayo Clinic

   Absolute neutrophil count ≥ 1500 cells/mm^3;; Calculated creatinine clearance ≥ 30 mL/min;; Bilirubin ≤ 1.5 mg/dL;; SGPT (ALT) and SGOT (AST) ≤ 2.5 times ...

4. Study to Evaluate the Efficacy and Safety of Gefapixant (MK-7264) in Adult Participants with Chronic Cough - Mayo Clinic

   ... neutrophil count <1500 mm3 (<1.5 × 103/uL), platelet count <100 × 103/mm3; (<100 × 103/uL). For any of the above listed laboratory assessments, 1 repeat ...

5. Study of Durvalumab + Tremelimumab With Chemotherapy or Durvalumab With Chemotherapy or Chemotherapy Alone for Patients With Lung Cancer (POSEIDON). - Mayo Clinic

   Absolute neutrophil count ≥1.5 × 109/L;; Platelet count ≥100 × 109/L;; Serum bilirubin ≤1.5 × ULN. This will not apply to patients with confirmed Gilbert's ...

6. Wild-Type Reovirus in Combination With Sargramostim in Treating Younger Patients With High-Grade Relapsed or Refractory Brain Tumors - Mayo Clinic

   Absolute neutrophil count (ANC) >= 750 /uL obtained =< 7 days prior to registration; Absolute lymphocyte count (ALC) >= 250/uL obtained =< 7 days prior to ...

7. PD 0332991 and Anastrozole for Stage 2 or 3 Estrogen Receptor Positive and HER2 Negative Breast Cancer - Mayo Clinic

   absolute neutrophil count ≥ 1,500/mcL; platelets ≥ 100,000/mcL; total bilirubin ≤ upper normal institutional limits; AST(SGOT)/ and ALT(SGPT) ≤ 2.5 X ...

8. A Study to Compare CMP-001 Combined with Nivolumab to Nivolumab Alone in Advanced Melanoma Subjects - Mayo Clinic

   Bone marrow function: Neutrophil count ≥ 1500/mm^3; · Liver function: Total bilirubin ≤1.5 × the upper limit of normal (ULN) with the following exception: ...

9. A Study to Determine the Safety, Tolerability and Pharmacokinetics of an Anti-PD-1 Monoclonal Antibody in Subjects With Advanced Malignancies - Mayo Clinic

   Absolute neutrophil count (ANC) ≥ 1.2 x 10^9/L (1,200/mm^3);; Platelet count ≥ 75 x 10^9/L (75,000/mm^3);; Total bilirubin ≤ 1.5 × upper limit of normal ...

10. Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus Nephritis - Mayo Clinic

    * Absolute neutrophil count (ANC) \< 0.8 x 1000/µL * Active viral, bacterial or other infections requiring intravenous or intramuscular treatment for ...